| First Author | Van Hove L | Year | 2021 |
| Journal | EMBO Rep | Volume | 22 |
| Issue | 5 | Pages | e51573 |
| PubMed ID | 33780134 | Mgi Jnum | J:306287 |
| Mgi Id | MGI:6711924 | Doi | 10.15252/embr.202051573 |
| Citation | Van Hove L, et al. (2021) Fibrotic enzymes modulate wound-induced skin tumorigenesis. EMBO Rep 22(5):e51573 |
| abstractText | Fibroblasts are a major component of the microenvironment of most solid tumours. Recent research elucidated a large heterogeneity and plasticity of activated fibroblasts, indicating that their role in cancer initiation, growth and metastasis is complex and context-dependent. Here, we performed genome-wide expression analysis comparing fibroblasts in normal, inflammatory and tumour-associated skin. Cancer-associated fibroblasts (CAFs) exhibit a fibrotic gene signature in wound-induced tumours, demonstrating persistent extracellular matrix (ECM) remodelling within these tumours. A top upregulated gene in mouse CAFs encodes for PRSS35, a protease capable of collagen remodelling. In human skin, we observed PRSS35 expression uniquely in the stroma of high-grade squamous cell carcinomas. Ablation of PRSS35 in mouse models of wound- or chemically-induced tumorigenesis resulted in aberrant collagen composition in the ECM and increased tumour incidence. Our results indicate that fibrotic enzymes expressed by CAFs can regulate squamous tumour initiation by remodelling the ECM. |
